Antti Tuokko
Papers
1
Total Citations
87
H-Index
1
About
Antti Tuokko is a pioneering researcher in the field of medical diagnostics, with a primary focus on the application of electronic nose (eNose) technology for noninvasive cancer detection. His most impactful contribution is the landmark 2014 study, "Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study," which has garnered 87 citations. In this work, Tuokko demonstrated that the ChemPro® 100-eNose could successfully discriminate between prostate cancer and benign prostatic hyperplasia by analyzing urine headspace, offering a rapid, noninvasive alternative to traditional diagnostic methods. This proof-of-principle study laid the groundwork for a new class of diagnostic tools, highlighting the potential of volatile organic compound analysis in clinical oncology. Tuokko's research bridges engineering and medicine, showcasing how sensor technology can address critical challenges in early cancer detection. His work continues to inspire further investigations into eNose applications, positioning him as a key figure in the development of accessible, point-of-care diagnostic solutions.
Research Focus
Key Achievements
Top Papers
- 1